Evidence map›Paper›PMID 36851237›Full record

ArticleVaccines2023

Sph2

Laura Sant'Anna Ataides, Fernanda de Moraes Maia, Fernando Paiva Conte, Lourdes Isaac, Angela Silva Barbosa, Josué da Costa Lima-Junior, Kátia Eliane Santos Avelar, Rodrigo Nunes Rodrigues-da-Silva

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Laura Sant'Anna AtaidesLaboratório de Tecnologia Imunológica, Instituto de Tecnologia em Imunobiológicos, FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
Fernanda de Moraes MaiaLaboratório de Tecnologia Imunológica, Instituto de Tecnologia em Imunobiológicos, FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
Fernando Paiva ConteLaboratório Piloto Eucariotos, Instituto de Tecnologia em Imunobiológicos, FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-1754-5870
Lourdes IsaacDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo 05508-000, SP, Brazil.
Angela Silva BarbosaLaboratório de Bacteriologia, Instituto Butantan, São Paulo 05503-900, SP, Brazil.ORCID 0000-0002-6458-9489
Josué da Costa Lima-JuniorLaboratório de Imunoparasitologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
Kátia Eliane Santos AvelarLaboratório de Referência Nacional para Leptospirose, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.
Rodrigo Nunes Rodrigues-da-SilvaLaboratório de Tecnologia Imunológica, Instituto de Tecnologia em Imunobiológicos, FIOCRUZ, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-9772-849X
Fundação Oswaldo Cruz · BRInstituto Butantan · BRUniversidade de São Paulo · BR

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 27/2021Inova Fiocruz/ Fundação Oswaldo Cruz 05/2021
6 · The paper itself

Abstract

Sphingomyelin is a major constituent of eukaryotic cell membranes, and if degraded by bacteria sphingomyelinases may contribute to the pathogenesis of infection. Among

Indexed as

B-cell epitopeimmunoinformaticleptospirosis

Identifiers

PMID36851237
PMCPMC9959207
OpenAlexW4319316010

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.